Immutep (IMMP) Net Income - Minority (2011)
Immutep's (IMMP) quarterly Net Income - Minority came in at $74.32 in Q2 2011.
Immutep (IMMP) Net Income - Minority (2011) Analysis & Trends
Immutep (IMMP) has 1 years of Net Income - Minority data on file, last reported at $74.32 in Q2 2011.
- Quarterly Net Income - Minority changed N/A year-over-year to $74.32 in Q2 2011, while the trailing twelve-month figure through Jun 2011 was $74.32 (changed N/A YoY) and the FY2011 annual result came in at $69.22, down 70.62% from the prior year.
- Net Income - Minority held at $74.32 in Q2 2011.
- In the past five years, Net Income - Minority ranged from a high of $74.32 in Q2 2011 to a low of $74.32 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 74.32 |